JP5677342B2 - Pili movement activator - Google Patents
Pili movement activator Download PDFInfo
- Publication number
- JP5677342B2 JP5677342B2 JP2012055191A JP2012055191A JP5677342B2 JP 5677342 B2 JP5677342 B2 JP 5677342B2 JP 2012055191 A JP2012055191 A JP 2012055191A JP 2012055191 A JP2012055191 A JP 2012055191A JP 5677342 B2 JP5677342 B2 JP 5677342B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- sample preparation
- preparation example
- menthol
- ciliary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000012190 activator Substances 0.000 title claims description 22
- 239000000284 extract Substances 0.000 claims description 88
- 230000001886 ciliary effect Effects 0.000 claims description 60
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 27
- 230000004899 motility Effects 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 239000002904 solvent Substances 0.000 claims description 11
- 235000009421 Myristica fragrans Nutrition 0.000 claims description 10
- 244000270834 Myristica fragrans Species 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 5
- 240000005125 Myrtus communis Species 0.000 claims description 3
- 235000013418 Myrtus communis Nutrition 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 description 66
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 46
- 230000000694 effects Effects 0.000 description 38
- 230000004913 activation Effects 0.000 description 37
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 26
- 239000000203 mixture Substances 0.000 description 26
- 235000009508 confectionery Nutrition 0.000 description 25
- 238000009472 formulation Methods 0.000 description 23
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 21
- 238000002156 mixing Methods 0.000 description 20
- 241000196324 Embryophyta Species 0.000 description 17
- 239000003205 fragrance Substances 0.000 description 16
- 229940002010 banana extract Drugs 0.000 description 15
- 235000015218 chewing gum Nutrition 0.000 description 14
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 13
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 13
- 210000003097 mucus Anatomy 0.000 description 13
- 240000002853 Nelumbo nucifera Species 0.000 description 12
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- NOOLISFMXDJSKH-AEJSXWLSSA-N (+)-menthol Chemical compound CC(C)[C@H]1CC[C@H](C)C[C@@H]1O NOOLISFMXDJSKH-AEJSXWLSSA-N 0.000 description 11
- 241000234295 Musa Species 0.000 description 11
- 235000009108 Urtica dioica Nutrition 0.000 description 11
- NOOLISFMXDJSKH-LPEHRKFASA-N Isomenthol Natural products CC(C)[C@@H]1CC[C@H](C)C[C@H]1O NOOLISFMXDJSKH-LPEHRKFASA-N 0.000 description 10
- 244000241872 Lycium chinense Species 0.000 description 10
- 235000015468 Lycium chinense Nutrition 0.000 description 10
- 241000733302 Lysichiton Species 0.000 description 10
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 10
- 241000949456 Zanthoxylum Species 0.000 description 10
- 229940112822 chewing gum Drugs 0.000 description 10
- 235000013399 edible fruits Nutrition 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 235000007650 Aralia spinosa Nutrition 0.000 description 9
- 241000219422 Urtica Species 0.000 description 9
- 235000005979 Citrus limon Nutrition 0.000 description 8
- 244000131522 Citrus pyriformis Species 0.000 description 8
- 235000015459 Lycium barbarum Nutrition 0.000 description 8
- 235000013361 beverage Nutrition 0.000 description 8
- 235000008995 european elder Nutrition 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 239000001702 nutmeg Substances 0.000 description 8
- 235000005976 Citrus sinensis Nutrition 0.000 description 7
- 240000002319 Citrus sinensis Species 0.000 description 7
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 7
- 241000543810 Sasa veitchii Species 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 239000000419 plant extract Substances 0.000 description 7
- 241000207199 Citrus Species 0.000 description 6
- 244000183685 Citrus aurantium Species 0.000 description 6
- 235000007716 Citrus aurantium Nutrition 0.000 description 6
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 206010036790 Productive cough Diseases 0.000 description 6
- 244000299461 Theobroma cacao Species 0.000 description 6
- 210000004081 cilia Anatomy 0.000 description 6
- 229940041616 menthol Drugs 0.000 description 6
- 208000024794 sputum Diseases 0.000 description 6
- 210000003802 sputum Anatomy 0.000 description 6
- 210000003437 trachea Anatomy 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 241000498779 Myristica Species 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 235000015895 biscuits Nutrition 0.000 description 5
- 235000019219 chocolate Nutrition 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 210000000981 epithelium Anatomy 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 235000015243 ice cream Nutrition 0.000 description 5
- 235000015110 jellies Nutrition 0.000 description 5
- 239000008274 jelly Substances 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000007923 nasal drop Substances 0.000 description 5
- 229940100662 nasal drops Drugs 0.000 description 5
- 229940116257 pepper extract Drugs 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- 241000208829 Sambucus Species 0.000 description 4
- 235000018735 Sambucus canadensis Nutrition 0.000 description 4
- 240000008866 Ziziphus nummularia Species 0.000 description 4
- 235000007123 blue elder Nutrition 0.000 description 4
- 235000020971 citrus fruits Nutrition 0.000 description 4
- 235000007124 elderberry Nutrition 0.000 description 4
- 235000020717 hawthorn extract Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241001107116 Castanospermum australe Species 0.000 description 3
- 241001092040 Crataegus Species 0.000 description 3
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 3
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 3
- 235000009685 Crataegus X maligna Nutrition 0.000 description 3
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 3
- 235000009486 Crataegus bullatus Nutrition 0.000 description 3
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 3
- 235000009682 Crataegus limnophila Nutrition 0.000 description 3
- 235000004423 Crataegus monogyna Nutrition 0.000 description 3
- 235000002313 Crataegus paludosa Nutrition 0.000 description 3
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 235000021279 black bean Nutrition 0.000 description 3
- 210000000254 ciliated cell Anatomy 0.000 description 3
- -1 inhalants Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229940098295 nutmeg extract Drugs 0.000 description 3
- 235000015205 orange juice Nutrition 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 235000013073 Acorus gramineus Nutrition 0.000 description 2
- 244000001632 Acorus gramineus Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- 235000003142 Sambucus nigra Nutrition 0.000 description 2
- 240000006028 Sambucus nigra Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 241001136126 Symplocarpus foetidus Species 0.000 description 2
- 244000274883 Urtica dioica Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 235000021015 bananas Nutrition 0.000 description 2
- 229940069765 bean extract Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000006059 cover glass Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 210000002175 goblet cell Anatomy 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000009747 swallowing Effects 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 241000679029 Citrus kinokuni Species 0.000 description 1
- 235000000228 Citrus myrtifolia Nutrition 0.000 description 1
- 235000009088 Citrus pyriformis Nutrition 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 235000016646 Citrus taiwanica Nutrition 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 235000003363 Cornus mas Nutrition 0.000 description 1
- 240000006766 Cornus mas Species 0.000 description 1
- 244000265913 Crataegus laevigata Species 0.000 description 1
- 235000013175 Crataegus laevigata Nutrition 0.000 description 1
- 235000017156 Crataegus rhipidophylla Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000282373 Panthera pardus Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- GBFLZEXEOZUWRN-VKHMYHEASA-N S-carboxymethyl-L-cysteine Chemical compound OC(=O)[C@@H](N)CSCC(O)=O GBFLZEXEOZUWRN-VKHMYHEASA-N 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- IOYNQIMAUDJVEI-BMVIKAAMSA-N Tepraloxydim Chemical group C1C(=O)C(C(=N/OC\C=C\Cl)/CC)=C(O)CC1C1CCOCC1 IOYNQIMAUDJVEI-BMVIKAAMSA-N 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 241001078984 Zanthoxylum americanum Species 0.000 description 1
- NTCYWJCEOILKNG-ROLPUNSJSA-N [(1r,2s)-1-hydroxy-1-phenylpropan-2-yl]-dimethylazanium;chloride Chemical compound Cl.CN(C)[C@@H](C)[C@H](O)C1=CC=CC=C1 NTCYWJCEOILKNG-ROLPUNSJSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 229960002335 bromhexine hydrochloride Drugs 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 229960004399 carbocisteine Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- 230000002060 circadian Effects 0.000 description 1
- 239000001666 citrus aurantium l. flower Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 229940073563 dl- methylephedrine hydrochloride Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- YRSGDLIATOURQO-UHFFFAOYSA-N ethyl 4-acetyl-5-oxohexanoate Chemical compound CCOC(=O)CCC(C(C)=O)C(C)=O YRSGDLIATOURQO-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940096428 hawthorn berry Drugs 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 235000015092 herbal tea Nutrition 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000004202 respiratory function Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
Description
本発明は、線毛運動活性化剤として気道から生産される粘液を輸送排出する能力を高め、結果として体内に吸入された細菌、異物等に対する生体防御能力を増強することを目的とする線毛運動活性化剤に関するものである。 The present invention aims to enhance the ability to transport and discharge mucus produced from the respiratory tract as a ciliary movement activator, and as a result, enhance the biological defense ability against bacteria, foreign substances and the like inhaled into the body. those related to the motion activator.
近年、大気汚染や気道に曝露される化学物質の増加により気道が慢性的に傷害され、気道上皮の排出能力が低下して喀痰の困難を訴える人が増加している。特に高齢者においては喀痰、嚥下能力が低下しており大きな問題となっている。 In recent years, the airway is chronically damaged due to an increase in chemical substances exposed to air pollution and the respiratory tract, and the number of people complaining of difficulty in hemorrhoids due to a decrease in the ability of the airway epithelium to discharge is increasing. Especially in elderly people, sputum and swallowing ability are reduced, which is a big problem.
特に、気管は粒子、ガス、粉塵、細菌、ウィルスといった異物に常に曝されている。これらの異物に対応するために気管の管腔側最表面に位置する気道粘膜上皮は異物排出機能を有し、気道腔を保護し、そして正常な呼吸機能を保存している。気道粘膜上皮は様々なタイプの細胞からなるが、その中で特に重要なものは粘液を産生する杯細胞と、線毛を有する線毛細胞である。粒子、ガス、粉塵、細菌、ウィルスなどの異物が気管に到達した際には杯細胞から生産される粘液がその異物を捉え、線毛細胞が有する線毛による能動的な運動(以下、線毛運動)により咽頭部分に運ばれ、痰としての体外排出もしくは嚥下により処理される。 In particular, the trachea is constantly exposed to foreign objects such as particles, gas, dust, bacteria and viruses. In order to deal with these foreign substances, the airway mucosal epithelium located at the outermost surface of the trachea has a function of discharging foreign substances, protects the airway cavity, and preserves normal respiratory function. The airway mucosal epithelium is composed of various types of cells, of which the most important are goblet cells that produce mucus and pilus cells that have pili. When foreign substances such as particles, gas, dust, bacteria, and viruses reach the trachea, mucus produced from goblet cells catches the foreign substances, and active movement by the cilia possessed by the ciliated cells (hereinafter, cilia) It is carried to the pharynx by movement) and processed by extracorporeal discharge or swallowing as a sputum.
線毛運動と粘液輸送の関係は流体力学的見地から公式(粘液輸送速度=粘液密度×線毛運動速度×線毛の丈/粘稠度)により導き出され、線毛運動が活発になると粘液輸送が亢進するものと考えられる。 The relationship between cilia movement and mucus transport is derived from the hydrodynamic viewpoint by the formula (mucus transport speed = mucus density x cilia movement speed x cilia length / viscosity), and when cilia movement becomes active, mucus transport Is thought to increase.
これまでの医療現場では咳と痰はマイナスの症状として捉えられてきた。特に咳に対しては呼吸の障害や体力消耗の元凶として安易に鎮咳剤を投与して異物排出の為の生理的反応である咳を抑え込む処置がとられる事が多かった。しかし、咳そのものを強硬に止めるのではなく、生理的な痰の排出を促し結果として咳を鎮める方が好ましいとの考え方が提唱され始めている。 Until now, cough and sputum have been seen as negative symptoms in medical practice. In particular, for coughs, antitussives were easily administered as a cause of respiratory problems and physical exhaustion, and treatments to suppress cough, which is a physiological reaction for foreign body excretion, were often taken. However, the idea that it is preferable to promote the discharge of physiological sputum and, as a result, calm the cough, instead of stopping the cough itself hard.
従来、痰の排出を促進する方法としては気道粘液を溶解して痰の粘稠度を下げる方法が採られ、カルボシステイン、塩酸ブロムヘキシン等の気道粘液溶解剤が用いられてきた(例えば、特許文献1参照)。しかし、化学合成品である気道粘液溶解剤そのものには発疹、湿疹、下痢、腹痛等の副作用が起こることが報告されている(例えば、非特許文献1参照)。 Conventionally, as a method for promoting the discharge of sputum, a method of lowering the consistency of sputum by dissolving airway mucus has been used, and airway mucus solubilizers such as carbocysteine and bromhexine hydrochloride have been used (for example, patent documents). 1). However, side effects such as rash, eczema, diarrhea, and abdominal pain have been reported to occur in the airway mucus solubilizing agent itself, which is a chemically synthesized product (see Non-Patent Document 1, for example).
上記の気道粘液溶解剤とは作用機序が異なり、気道上皮の線毛運動を活性化させる物質にも粘液輸送を亢進することで異物排出能力を高める効果があることは知られている。安全性に問題が少ないという点から天然物である植物から線毛運動活性化効果を有する抽出物の探索が行われており、ナツメ(例えば、非特許文献2参照)、クロマメ(例えば、非特許文献3参照)等が開示されているが、十分な線毛運動活性化効果を有する抽出物は未だ得られていないのが現状である。 It is known that the mechanism of action is different from that of the above airway mucus solubilizer, and substances that activate ciliary movement of the airway epithelium also have an effect of enhancing foreign matter excretion ability by enhancing mucus transport. Searches for extracts having a ciliary motility activation effect from plants that are natural products from the viewpoint that there are few problems with safety are jujube (see, for example, Non-Patent Document 2), black beans (for example, non-patent) However, an extract having a sufficient effect of activating ciliary movement has not been obtained yet.
本発明は、上記のような従来技術の問題点を解決するためになされたもので、安全かつ効果の高い線毛運動活性化剤を提供することを目的としている。 The present invention has been made in order to solve the above-described problems of the prior art, and an object thereof is to provide a safe and highly effective ciliary movement activator.
上記課題を解決するため、本発明者らは、広く線毛運動活性化効果を示す物質のスクリーニングを行った結果、ニクズク(Myristica fragrans)の仮種皮に対し、水もしくはアルコールの溶媒にて抽出した抽出物が線毛運動活性化効果を有することを見出し、本発明を完成させるに至った。 In order to solve the above-mentioned problems, the present inventors conducted extensive screening for substances exhibiting a ciliary motility activation effect, and as a result, extracted with water or an alcohol solvent for the temporary seed coat of myrtle (Myristica fragrans) . The present inventors have found that the extract has a ciliary motility activation effect and have completed the present invention.
すなわち、本発明は、ニクズク(Myristica fragrans)の仮種皮に対し、水もしくはアルコールの溶媒にて抽出した抽出物を有効成分とする線毛運動活性化剤である。 That is, the present invention is a ciliary motility activator comprising, as an active ingredient, an extract extracted from water or an alcohol solvent with respect to a temporary seed coat of myrtle (Myristica fragrans).
本発明の線毛運動活性化剤は古くから生薬や民間伝承的に用いられている植物の抽出物及び/又は一般的に飲食品に配合されているメントール、メントール誘導体、メントール異性体等を使用するものであるから、呈味に優れ、かつ安全性の点で問題はない。そのため、本発明の線毛運動活性化剤及びそれを含む飲食品は、化学合成品からなる気道粘液溶解剤のような副作用を伴わずに、外来の細菌、ウィルス、異物等に由来する感染症(気管支炎、気管支拡張症、副鼻腔炎、気管支喘息、肺炎等)の疾患を予防することができる。 The ciliary motility activator of the present invention uses menthol, menthol derivatives, menthol isomers, etc., which have been used in herbal medicines and folklore for a long time, and / or menthol derivatives generally used in foods and drinks. Therefore, there is no problem in terms of safety and excellent taste. Therefore, the ciliary movement activator of the present invention and foods and drinks containing the same are not accompanied by side effects such as airway mucus solubilizers composed of chemically synthesized products, and infectious diseases derived from foreign bacteria, viruses, foreign substances, etc. Diseases (bronchitis, bronchiectasis, sinusitis, bronchial asthma, pneumonia, etc.) can be prevented.
本発明で使用する植物、バショウ科バショウ属(Musaceae Musa)植物、ニクズク(Myristica fragrans)、ミカン科ミカン属(Rutaceae Citrus)植物、スカンクキャベッジ(Symplocarpus foetidus)、セキショウ(Acorus gramineus)、プリックリーアッシュ(Zanthoxylum americanum)、クコ(Lycium chinense)、ネトル(Urtica dioica)、ハス(Nelumbo nucifera)、セイヨウニワトコ(Sambucus nigra)、クマザサ(Sasa veitchii)及びセイヨウサンザシ(Crataegus oxyacantha)は、その全体、葉、仁、胚芽、内果皮、外果皮、成熟果実、未熟果実、果皮、種皮、仮種皮、花、材、樹皮、根、根茎等の部位を使用することができるが、ニクズクに関しては仮種皮(メース)を、スカンクキャベッジに関しては根茎を、セキショウに関しては根を、プリックリーアッシュに関しては樹皮を、クコ、ネトル及びクマザサに関しては葉を、ハスに関しては胚芽を、セイヨウニワトコに関しては花を、セイヨウサンザシについては実を用いるのが好ましい。 Plants used in the present invention, Musaceae Musa plant, Myristica fragrans, Rutaceae Citrus plant, Skunk cabbage (Symplocarpus foetidus), Sekisho (Acorus gramineus), Prickly ash ( Zanthoxylum americanum, Lycium chinense, Nettle (Urtica dioica), Lotus (Nelumbo nucifera), Sambucus nigra, Sasa veitchii, and Crataeegus oxyacantha You can use parts such as germ, endocarp, outer pericarp, mature fruit, immature fruit, pericarp, seed coat, temporary seed coat, flower, wood, bark, root, rhizome, etc. For skunk cabbage, rhizomes, for roots, roots for prickly ash, bark, wolfberry, neto It is preferred to use leaves for le and kumaza, germs for lotus, flowers for elderberry, and fruit for hawthorn.
バショウ科バショウ属植物については、本種属に含まれていれば特に植物の種類は限定しないが、バナナ(Musa paradisiaca)、リョウリバナナ(Musa sapientum)、マライヤマバショウ(Musa acuminata)を使用する事が好ましい。またバショウ科バショウ属において抽出に供する為の植物部位については、果実、果皮を使用する事が好ましい。 As long as it is included in the genus of the genus Baxaceae, the type of the plant is not particularly limited. Is preferred. Moreover, it is preferable to use a fruit and pericarp for the plant part for extraction in the genus Bacillus.
ミカン科ミカン属植物については、本種属に含まれていれば特に植物の種類は限定しないが、ダイダイ(Citrus aurantium)、キシュウミカン(Citrus kinokuni)、ネーブルオレンジ(Citrus sinensis)、レモン(Citrus limon)、ニッポンタチバナ(Citrus tachibana)を使用する事が好ましい。またミカン科ミカン属において抽出に供する為の植物部位については、果実、果皮、花、葉を使用する事が好ましい。 As for the mandarin orange genus plants, the type of the plant is not particularly limited as long as it is included in this species, but Daidai (Citrus aurantium), Citrus kinokuni, Navel orange (Citrus sinensis), Lemon (Citrus limon) ), It is preferable to use Nippon tachibana. Moreover, it is preferable to use a fruit, a skin, a flower, and a leaf about the plant site | part for providing to extraction in the citrus genus Citrus.
本発明の線毛運動活性化剤としては、各植物をそのまま有効成分として含有させても良いが、乾燥させたもの、更に乾燥物を粉末化したものを有効成分として含有させても良い。また、各植物より抽出された抽出物を有効成分として含有させても良い。この植物抽出物とは、各種溶剤で抽出された液状エキスであっても良いが、更にこの液状エキスを通常の乾燥方法(例えば、減圧乾燥、凍結乾燥等)や濃縮方法等により乾固又は濃縮したものであっても良い。溶剤の種類は特に限定されず、水(熱水)の他にエタノール、メタノール、プロパノール、グリセリン、プロピレングリコール等のアルコール類や、エーテル、アセトン、酢酸エチル、クロロホルム、ヘキサン等の有機溶剤またはこれらを適宜混合した溶剤を用いることができるが、線毛運動活性化剤として経口摂取する場合を考慮すると、安全性の面から水、エタノールもしくはその混合溶液を用いて抽出することが望ましい。また更に、この植物抽出物に対し、必要に応じてその効果に影響が無い範囲で脱臭、脱色等の精製処理を施しても良い。 As a ciliary movement activator of this invention, you may contain each plant as an active ingredient as it is, but you may contain what dried and also powdered the dried material as an active ingredient. Moreover, you may contain the extract extracted from each plant as an active ingredient. The plant extract may be a liquid extract extracted with various solvents, but the liquid extract is further solidified or concentrated by an ordinary drying method (for example, reduced pressure drying, freeze drying, etc.) or a concentration method. It may be what you did. The type of the solvent is not particularly limited. In addition to water (hot water), alcohols such as ethanol, methanol, propanol, glycerin and propylene glycol, organic solvents such as ether, acetone, ethyl acetate, chloroform and hexane or these Solvents mixed as appropriate can be used, but taking into account the case of oral ingestion as a ciliary movement activator, extraction from water, ethanol or a mixed solution thereof is desirable from the viewpoint of safety. Furthermore, you may perform refinement | purification processes, such as deodorizing and decoloring, to this plant extract in the range which does not affect the effect as needed.
上記植物より抽出物を得るための抽出条件としては、特に制限はないが、50〜100℃で1〜5時間程度が好ましい。抽出液はさらに濾過し、抽出溶剤を留去したあと、減圧下において濃縮または凍結乾燥したものを使用することができる。また、これらの抽出物を有機溶剤分画、カラムクロマトグラフィー等により分画精製したものを使用することもできる。 The extraction condition for obtaining the extract from the plant is not particularly limited, but is preferably about 1 to 5 hours at 50 to 100 ° C. The extract can be further filtered and the extract solvent is distilled off, and then concentrated or lyophilized under reduced pressure. Further, those obtained by fractionating and purifying these extracts by organic solvent fractionation, column chromatography or the like can also be used.
本発明で使用するメントール、メントール誘導体及びメントール異性体としてはL−メントール、D−メントール、メンチルアセテート、イソメントール等が含まれるがこれらに限定されるものではない。メントール、メントール誘導体及びメントール異性体はカプセル化(マイクロカプセル化)されたものあるいはサイクロデキストリン等により包接化されたものであってもよい。また、これらを含有する精油又は調合香料等を使用しても良く、例えばペパーミント油(薄荷油)等の精油を使用することも可能である。 Menthol, menthol derivatives and menthol isomers used in the present invention include, but are not limited to, L-menthol, D-menthol, menthyl acetate, isomenthol and the like. Menthol, menthol derivatives and menthol isomers may be encapsulated (microencapsulated) or encapsulated with cyclodextrin or the like. Moreover, you may use the essential oil containing these, a blended fragrance | flavor, etc., for example, it is also possible to use essential oils, such as peppermint oil (light-loading oil).
本発明の線毛運動活性化剤は、必要により適当な液体単体に溶解するか或いは分散させ、または適当な粉末単体と混合するか或いはこれに吸着させ、場合によっては、さらにこれに乳化剤、安定剤、分散剤、矯味剤、保存剤、芳香剤、着色剤、コーティング剤等を添加して、錠剤、液剤、注射剤、軟膏、クリーム、ローション、スプレー剤、エアゾール剤、座剤等の所望の剤型にして、経口剤、外用剤、注射剤、吸入剤、点鼻・点眼剤等として使用してもよい。この場合の添加量としては、剤に対して植物抽出物及び/又は化合物を0.001重量%以上、好ましくは0.01重量%以上使用するのが好適である。 The ciliary motility activator of the present invention is dissolved or dispersed in an appropriate liquid alone, if necessary, mixed with an appropriate powder alone or adsorbed thereto, and in some cases, an emulsifier, Add additives, dispersants, flavoring agents, preservatives, fragrances, coloring agents, coating agents, etc., as desired tablets, liquids, injections, ointments, creams, lotions, sprays, aerosols, suppositories, etc. The dosage form may be used as oral preparations, external preparations, injections, inhalants, nasal drops, eye drops and the like. In this case, it is suitable to use 0.001% by weight or more, preferably 0.01% by weight or more of the plant extract and / or compound with respect to the agent.
また、本発明の線毛運動活性化剤は、香り、呈味性に優れ、安全性が高いことから、チューインガム、キャンディ、錠菓、グミゼリー、チョコレート、ビスケット等の菓子、アイスクリーム、シャーベット、氷菓等の冷菓、飲料、スープ、ジャム等の飲食品に配合して日常的に利用することが可能である。 Further, the ciliary movement activator of the present invention is excellent in fragrance, taste, and safety, so it is a confectionery such as chewing gum, candy, tablet confectionery, gummy jelly, chocolate, biscuits, ice cream, sorbet, ice confectionery. It can be used on a daily basis by blending it into food and drink such as frozen desserts, beverages, soups, jams and the like.
本発明の飲食品への線毛運動活性化剤添加量としては、特に嗜好性の面を考慮すると約0.001〜5重量%、好ましくは約0.01〜3重量%の割合になるように添加するのが好適である。 The amount of ciliary movement activator added to the food or drink of the present invention is about 0.001 to 5% by weight, preferably about 0.01 to 3% by weight, especially considering the aspect of palatability. It is suitable to add to.
本発明で使用するバショウ科バショウ属(Musaceae Musa)植物、ニクズク(Myristica fragrans)、ミカン科ミカン属(Rutaceae Citrus)植物、スカンクキャベッジ(Symplocarpus foetidus)、セキショウ(Acorus gramineus)、プリックリーアッシュ(Zanthoxylum americanum)、クコ(Lycium chinense)、ネトル(Urtica dioica)、ハス(Nelumbo nucifera)、セイヨウニワトコ(Sambucus nigra)、クマザサ(Sasa veitchii)及びセイヨウサンザシ(Crataegus oxyacantha)は、いずれも生薬、食品素材、ハーブティーとして古くから用いられているものであり、これらの抽出物並びにこれを配合した飲食品の安全性について全く問題がない。また、メントール、メントール誘導体及びメントール異性体は一般的に飲食品に配合されているものであるので安全性について全く問題がない。 Musaceae Musa plant, Myristica fragrans, Rutaceae Citrus plant, Skunk cabbage (Symplocarpus foetidus), Sekisho (Acorus gramineus), Prickly american um (Zanthoxylum american) used in the present invention ), Lycium chinense, Nettle (Urtica dioica), Lotus (Nelumbo nucifera), Sambucus nigra, Sasa veitchii, and Crataegus oxyacantha are all herbal medicines, food ingredients, herbal teas It has been used for a long time, and there is no problem at all about the safety of these extracts and foods and drinks containing them. In addition, since menthol, menthol derivatives and menthol isomers are generally blended in foods and drinks, there is no safety problem.
以下、試験例を挙げて本発明を具体的に説明するが、本発明はこれらに限定されるものではない。 Hereinafter, the present invention will be specifically described with reference to test examples, but the present invention is not limited thereto.
本試験は、植物体より得られた植物抽出物の線毛運動活性化効果を調べるために、行なった。 This test was conducted to examine the effect of pilus motility activation of plant extracts obtained from plants.
1)供試試料
以下に述べる方法にて植物抽出物を調製した。
1) Test sample A plant extract was prepared by the method described below.
〔試料調製例1〕
乾燥し破砕したリョウリバナナの果皮、ニクズクの仮種皮、プリックリーアッシュの樹皮、クマザサの葉、セイヨウサンザシの実それぞれ10gに100mlの50%エタノールを加え、2時間、70℃で還流抽出を行った。得られた各抽出液を個別に濾過し、濃縮、凍結乾燥することにより、本発明である線毛運動活性化剤を得た。ニクズク抽出物は2.1g、リョウリバナナ抽出物は4.2g、プリックリーアッシュ抽出物は0.6g、クマザサ抽出物は0.7g、セイヨウサンザシ抽出物は1.3g得られた。
[Sample Preparation Example 1]
100 ml of 50% ethanol was added to 10 g each of dried and crushed rye banana peel, nutmeg temporary seed coat, prickly ash bark, kumaza leaf, and hawthorn berries, and refluxed at 70 ° C. for 2 hours. . Each obtained extract was individually filtered, concentrated and freeze-dried to obtain a ciliary motility activator according to the present invention. 2.1 g of nutmeg extract, 4.2 g of licorice banana extract, 0.6 g of prickly ash extract, 0.7 g of kumazasa extract, and 1.3 g of hawthorn extract were obtained.
〔試料調製例2〕
乾燥し破砕したバナナの果皮、ニクズクの仮種皮、プリックリーアッシュの樹皮、クマザサの葉、セイヨウサンザシの実それぞれ10gに100mlの水を加え、2時間、70℃で還流抽出を行った。得られた各抽出液を個別に濾過し、濃縮、凍結乾燥することにより、本発明である線毛運動活性化剤を得た。ニクズク抽出物は2.1g、バナナ抽出物は2.8g、プリックリーアッシュ抽出物は0.5g、クマザサ抽出物は0.7g、セイヨウサンザシ抽出物は0.9g得られた。
[Sample Preparation Example 2]
100 ml of water was added to 10 g each of dried and crushed banana peel, nutmeg temporary seed coat, prickly ash bark, kumaza leaf, and hawthorn berry, and refluxed at 70 ° C. for 2 hours. Each obtained extract was individually filtered, concentrated and freeze-dried to obtain a ciliary motility activator according to the present invention. The nutmeg extract was 2.1 g, the banana extract was 2.8 g, the prickly ash extract was 0.5 g, the kumazasa extract was 0.7 g, and the hawthorn extract was 0.9 g.
〔試料調製例3〕
乾燥し破砕したスカンクキャベッジの根茎、セキショウの根、マライヤマバショウの実、ハスの胚芽、セイヨウニワトコの花それぞれ10gに100mlの50%エタノールを加え、2時間、70℃で還流抽出を行った。得られた各抽出液を個別に濾過し、濃縮、凍結乾燥することにより、本発明である線毛運動活性化剤を得た。スカンクキャベッジ抽出物は2.3g、セキショウ抽出物は0.6g、マライヤマバショウ抽出物は4.0g、ハス抽出物は2.4g、セイヨウニワトコ抽出物は2.3g得られた。
[Sample Preparation Example 3]
100 ml of 50% ethanol was added to 10 g each of dried and crushed skunk cabbage rhizome, buffalo root, sunflower seed, lotus germ, and elderflower, followed by reflux extraction at 70 ° C. for 2 hours. Each obtained extract was individually filtered, concentrated and freeze-dried to obtain a ciliary motility activator according to the present invention. As a result, 2.3 g of the skunk cabbage extract, 0.6 g of the birch extract, 4.0 g of the Malayan bay pepper extract, 2.4 g of the lotus extract, and 2.3 g of the elderberry extract were obtained.
〔試料調製例4〕
乾燥し破砕したスカンクキャベッジの根茎、セキショウの根、バナナの実、ハスの胚芽、セイヨウニワトコの花、キシュウミカンの果皮、レモンの葉それぞれ10gに100mlの水を加え、3時間、70℃で還流抽出を行った。得られた抽出液を個別に濾過し、濃縮、凍結乾燥することにより、本発明である線毛運動活性化剤を得た。スカンクキャベッジ抽出物は2.3g、セキショウ抽出物は1.5g、バナナ抽出物は4.0g、ハス抽出物は2.7g、セイヨウニワトコ抽出物は2.1g、キシュウミカン抽出物は3.1g、レモン抽出物は2.6g得られた。
[Sample Preparation Example 4]
Add 100 ml of water to 10 g each of dried and crushed skunk cabbage rhizome, pebbles root, banana fruit, lotus germ, elderflower flower, citrus peel and lemon leaf, and reflux at 70 ° C. for 3 hours. Extraction was performed. The obtained extract was individually filtered, concentrated, and lyophilized to obtain a ciliary motility activator according to the present invention. The skunk cabbage extract is 2.3 g, the biloba extract is 1.5 g, the banana extract is 4.0 g, the lotus extract is 2.7 g, the elderberry extract is 2.1 g, and the citrus orange extract is 3.1 g. 2.6 g of lemon extract was obtained.
〔試料調製例5〕
乾燥し破砕したネーブルオレンジの花、クコの葉、ネトルの葉それぞれ30gに300mlの50%エタノールを加え、1時間、90℃で抽出を行った。得られた各抽出液を個別に濾過し、濃縮、凍結乾燥することにより、本発明である線毛運動活性化剤を得た。ネーブルオレンジ抽出物は6.9g、クコ抽出物は8.4g、ネトル抽出物は3.3g得られた。
[Sample Preparation Example 5]
300 ml of 50% ethanol was added to 30 g each of dried and crushed navel orange flowers, wolfberry leaves and nettle leaves and extracted at 90 ° C. for 1 hour. Each obtained extract was individually filtered, concentrated and freeze-dried to obtain a ciliary motility activator according to the present invention. 6.9 g of navel orange extract, 8.4 g of wolfberry extract, and 3.3 g of nettle extract were obtained.
〔試料調製例6〕
乾燥し破砕したニッポンタチバナの果実、クコの葉、ネトルの葉それぞれ30gに300mlの水を加え、1時間、90℃で抽出を行った。得られた抽出液を濾過し、濃縮、凍結乾燥することにより、本発明である線毛運動活性化剤を得た。ニッポンタチバナ抽出物は7.8g、クコ抽出物は8.4g、ネトル抽出物は5.4g得られた。
[Sample Preparation Example 6]
300 ml of water was added to 30 g of each dried and crushed Nippon Tachibana fruit, wolfberry leaf, and nettle leaf, and extracted at 90 ° C. for 1 hour. The obtained extract was filtered, concentrated, and lyophilized to obtain a ciliary motility activator according to the present invention. 7.8 g of Nippon Tachibana extract, 8.4 g of wolfberry extract, and 5.4 g of nettle extract were obtained.
〔試料調製例7〕
乾燥し破砕したリョウリバナナの果皮、ニクズクの仮種皮それぞれ10gに100mlの100%メタノールを加え、3時間、70℃で抽出を行った。得られた抽出液を濾過し、濃縮、減圧乾燥することにより、本発明である線毛運動活性化剤を得た。リョウリバナナ抽出物は1.0g、ニクズク抽出物は1.4g得られた。
[Sample Preparation Example 7]
100 g of 100% methanol was added to 10 g each of dried and crushed rye banana peel and nutmeg temporary seed coat and extracted at 70 ° C. for 3 hours. The obtained extract was filtered, concentrated and dried under reduced pressure to obtain a ciliary motility activator according to the present invention. 1.0 g of ryori banana extract and 1.4 g of nutmeg extract were obtained.
〔試料調製例8〕
乾燥し破砕したバナナの果皮、セキショウの根茎、ダイダイの果実それぞれ10gに100mlの100%エタノールを加え、3時間、70℃で抽出を行った。得られた抽出液を濾過し、濃縮、減圧乾燥することにより、本発明である線毛運動活性化剤を得た。バナナ抽出物は1.2g、セキショウ抽出物は0.5g、ダイダイ抽出物は1.9g得られた。
[Sample Preparation Example 8]
100 ml of 100% ethanol was added to 10 g each of dried and crushed banana peels, red rhizomes, and Daidai fruits, and extracted at 70 ° C. for 3 hours. The obtained extract was filtered, concentrated and dried under reduced pressure to obtain a ciliary motility activator according to the present invention. As a result, 1.2 g of banana extract, 0.5 g of pepper extract, and 1.9 g of Daidai extract were obtained.
〔比較試料1〕
乾燥し破砕したナツメの果実30gに300mlの水を加え、1時間、90℃で還流抽出を行った。得られた抽出液を濾過し、濃縮、凍結乾燥することによりナツメ抽出物15.3gを得た。
[Comparative sample 1]
300 ml of water was added to 30 g of dried and crushed jujube fruits, followed by reflux extraction at 90 ° C. for 1 hour. The obtained extract was filtered, concentrated and freeze-dried to obtain 15.3 g of jujube extract.
〔比較試料2〕
乾燥し破砕したクロマメの果実30gに300mlの水を加え、2時間、70℃で還流抽出を行った。得られた抽出液を濾過し、濃縮、凍結乾燥することにより黒豆抽出物11.1gを得た。
[Comparative sample 2]
300 ml of water was added to 30 g of dried and crushed blackberry fruits, followed by reflux extraction at 70 ° C. for 2 hours. The obtained extract was filtered, concentrated and freeze-dried to obtain 11.1 g of a black bean extract.
2)試験法
試料調製例1〜8で示した本発明品である線毛運動活性化剤及び比較例1、2で示した比較抽出物を試料として、線毛運動活性化効果を調べた。
2) Test method Using the ciliary motility activator of the present invention shown in Sample Preparation Examples 1 to 8 and the comparative extract shown in Comparative Examples 1 and 2 as samples, the ciliary motility activation effect was examined.
本試験は、ウサギの気管より摘出した線毛細胞の線毛運動を測定し、植物抽出物が線毛運動を活性化する効果を確認するものである。 This test measures the ciliary movement of ciliated cells extracted from the rabbit trachea and confirms the effect of the plant extract activating ciliary movement.
日本白色種ウサギ(2.0〜2.3kg)をペントバルビタールナトリウム麻酔下に、気管を摘出し、気管から線毛細胞を含む気道粘膜上皮を剥離し、1〜3mm2の小片に細断した後Medium199(ペニシリン50U/ml、ストレプトマイシン50μg/ml、ファンギゾン2.5μg/mlを含有)で満たしたシャーレ内のカバーグラスに置いた。 A Japanese white rabbit (2.0-2.3 kg) was anesthetized with pentobarbital sodium, the trachea was removed, the airway mucosa epithelium containing ciliated cells was peeled from the trachea, and cut into small pieces of 1-3 mm 2 . Thereafter, it was placed on a cover glass in a petri dish filled with Medium 199 (containing penicillin 50 U / ml, streptomycin 50 μg / ml, fungizone 2.5 μg / ml).
37℃条件下にCO2インキュベーター(95%空気、5%CO2)で7日間培養を行った。組織は約30度傾斜させたカバーグラスの気相面に貼付し、48時間後にシャーレを水平にして培養を継続した。次いでこれを逆さまにしてMedium199で満たしたローズチャンバー内に固定、マイクロフォトオシレーション法で線毛運動周波数(以下「CBF」と省略する)を測定した(岡沢光芝ら 線毛運動の解析法、呼吸5:1345〜1350、1986年)。 Cultivation was performed for 7 days in a CO 2 incubator (95% air, 5% CO 2 ) under 37 ° C conditions. The tissue was affixed to the gas phase surface of a cover glass inclined at about 30 degrees, and the culture was continued with the petri dish horizontal after 48 hours. Next, this was turned upside down and fixed in a rose chamber filled with Medium 199, and the ciliary motion frequency (hereinafter abbreviated as “CBF”) was measured by the microphotooscillation method (Okazawa Mitsushiba et al. Respiration 5: 1345-1350, 1986).
測定は37℃の恒温槽内で実施した。まずMedium199でローズチャンバー内を灌流してCBFを15分連続して測定、次いでほぼ同一部位のCBFを試料添加Medium199で灌流してCBFを15分連続して測定、前者を基礎値として変化率を以下の式に従って算出した。 The measurement was carried out in a constant temperature bath at 37 ° C. First, permeate the rose chamber with Medium 199 and measure CBF continuously for 15 minutes, then perfuse CBF at almost the same site with Sample 199 and measure CBF continuously for 15 minutes. Calculation was performed according to the following formula.
線毛運動活性化率(%)=(A/B−1)×100
但し、A:試料添加Medium199で灌流した後15分間のCBFの平均値
B:Medium199で灌流した後15分間のCBFの平均値(基礎値)
Ciliary motor activation rate (%) = (A / B-1) × 100
However, A: Average value of CBF for 15 minutes after perfusion with Sample-added Medium 199 B: Average value of CBF for 15 minutes after perfusion with Medium 199 (basic value)
3)試験結果
それぞれの試料の1mg/mlでの線毛運動活性化率を表1に示した。
3) Test results Table 1 shows the activation rate of ciliary motility of each sample at 1 mg / ml.
表1の結果より、本発明のバナナ、リョウリバナナ、ニクズク、マライヤマバショウ、プリックリーアッシュ、スカンクキャベッジ、セキショウ、ダイダイ、キシュウミカン、ネーブルオレンジ、レモン、ニッポンタチバナ、クコ、ネトル、ハス、セイヨウニワトコ、クマザサ、セイヨウサンザシから調製された抽出物は、強い線毛運動活性化作用を示したが、比較例であるナツメ抽出物及びクロマメ抽出物の線毛運動活性化作用については、弱いものであった。 From the results shown in Table 1, the present invention bananas, leopard bananas, nutmeg, malaysian mackerel, prickly ash, skunk cabbage, red pepper, daidai, kishu mikan, navel orange, lemon, nippon tachibana, wolfberry, nettle, lotus, elderberry The extracts prepared from crisp, Kumazasa, and Hawthorn showed strong ciliary motility activation, but the circadian motility activation of jujube extract and black bean extract, which are comparative examples, was weak. It was.
本試験は、メントール、メントール誘導体及びメントール異性体の線毛運動活性化効果を調べるために、行なった。
1)供試試料
L−メントール、D−メントール、イソメントール及びメンチルアセテートを用いた。
2)試験方法
本試験は試験例1と同じ試験方法で行なった。
3)試験結果
各試料の50μg/mlでの線毛運動活性化率を表2に示した。
This test was conducted to examine the effect of menthol, menthol derivatives and menthol isomers on ciliary motility activation.
1) Test samples L-menthol, D-menthol, isomenthol and menthyl acetate were used.
2) Test method This test was conducted by the same test method as in Test Example 1.
3) Test results Table 2 shows the activation rate of ciliary movement of each sample at 50 μg / ml.
表2の結果より、L−メントール、D−メントール、イソメントール、メンチルアセテート何れも強い線毛運動活性化作用を示した。 From the results of Table 2, L-menthol, D-menthol, isomenthol, and menthyl acetate all showed a strong ciliary motility activation effect.
以下、実施例を挙げて本発明を更に具体的に説明するが、本発明はこれらに限定されるものではない。 EXAMPLES Hereinafter, the present invention will be described more specifically with reference to examples, but the present invention is not limited to these examples.
試料調製例1乃至8で調製した植物抽出物、乾燥させた植物を粉砕して調製した植物粉末、メントール、メントール誘導体及びメントール異性体を用いて、錠剤、散剤、吸入剤、点鼻薬、チューインガム、キャンディ、チョコレート、ビスケット、グミゼリー、錠菓、アイスクリーム、シャーベット、飲料を常法にて調製した。以下にその処方を示した。 Using the plant extract prepared in Sample Preparation Examples 1 to 8, plant powder prepared by crushing dried plants, menthol, menthol derivatives and menthol isomers, tablets, powders, inhalants, nasal drops, chewing gum, Candy, chocolate, biscuits, gummy jelly, tablet confectionery, ice cream, sherbet, and beverage were prepared by conventional methods. The prescription is shown below.
下記処方にしたがって錠剤を調製した。
D−マンニトール 42.6%
乳糖 42.6
結晶セルロース 8.5
ヒドロキシプロピルセルロース 4.3
試料調製例4のスカンクキャベッジ抽出物 2.0
100.0%
Tablets were prepared according to the following formulation.
D-mannitol 42.6%
Lactose 42.6
Crystalline cellulose 8.5
Hydroxypropylcellulose 4.3
Skunk Cabbage Extract 2.0 of Sample Preparation Example 2.0
100.0%
上記と同じ配合比率で、スカンクキャベッジ抽出物の代わりに試料調製例1乃至試料調製例8の各抽出物を配合した錠剤をそれぞれ同様に調製した。これらは錠剤としての性質を損なうことなく線毛運動活性化効果を有していた。 Tablets containing the extracts of Sample Preparation Example 1 to Sample Preparation Example 8 in the same manner as described above were prepared in the same manner instead of the skunk cabbage extract. These had a ciliary movement activation effect without impairing the properties as a tablet.
下記処方にしたがって散剤を調製した。
乳糖 62.5%
馬鈴薯でんぷん 25.0
試料調製例6のネトル抽出物 12.5
100.0%
A powder was prepared according to the following formulation.
Lactose 62.5%
Potato starch 25.0
Nettle extract of sample preparation example 6 12.5
100.0%
上記と同じ配合比率で、ネトル抽出物の代わりに試料調製例1乃至試料調製例8の各抽出物を配合した散剤をそれぞれ同様に調製した。これらは散剤としての性質を損なうことなく線毛運動活性化効果を有していた。 Powders containing the extracts of Sample Preparation Example 1 to Sample Preparation Example 8 were prepared in the same manner in the same mixing ratio as above, instead of the nettle extract. These had a ciliary movement activation effect without impairing the properties as a powder.
下記処方にしたがって吸入剤を調製した。
エタノール 5.0%
試料調製例1のプリックリーアッシュ抽出物 0.5
試料調製例5のネーブルオレンジ抽出物 0.5
L−メントール 2.0
水 92.0
100.0%
An inhalant was prepared according to the following formulation.
Ethanol 5.0%
Prickly ash extract of Sample Preparation Example 1 0.5
Navel orange extract of Sample Preparation Example 5 0.5
L-Menthol 2.0
Water 92.0
100.0%
上記と同じ配合比率で、プリックリーアッシュ抽出物、ネーブルオレンジ抽出物の代わりに試料調製例1乃至試料調製例8の各抽出物を配合した吸入剤をそれぞれ同様に調製した。これらは吸入剤としての性質を損なうことなく線毛運動活性化効果を有していた。 Inhalants were prepared in the same manner with the same blending ratios as above, but blended with each extract of Sample Preparation Example 1 to Sample Preparation Example 8 instead of Prickly Ash Extract and Navel Orange Extract. These had a ciliary movement activation effect without impairing the properties as an inhalant.
下記処方にしたがって点鼻薬を調製した。
サリチル酸メチル 0.03g
マレイン酸クロルフェニラミン 0.3
dl―塩酸メチルエフェドリン 0.3
ポリソルベート80 0.2
塩化ベンザルコニウム 0.01
塩化ナトリウム 0.6
1N水酸化ナトリウム 適量
試料調製例2のニクズク抽出物 1.0
水 適量
100.0ml(pH6.5)
Nasal drops were prepared according to the following prescription.
Methyl salicylate 0.03g
Chlorpheniramine maleate 0.3
dl-methylephedrine hydrochloride 0.3
Polysorbate 80 0.2
Benzalkonium chloride 0.01
Sodium chloride 0.6
1N sodium hydroxide appropriate amount Sample extract 2 of sample preparation 1.0
Appropriate amount of water
100.0 ml (pH 6.5)
上記と同じ配合比率で、ニクズク抽出物の代わりに試料調製例1乃至試料調製例8の各抽出物を配合した点鼻薬をそれぞれ同様に調製した。これらは点鼻薬としての性質を損なうことなく線毛運動活性化効果を有していた。 Nasal drops containing the extracts of Sample Preparation Example 1 to Sample Preparation Example 8 were prepared in the same manner in the same mixing ratio as above. These had a ciliary motility activation effect without impairing the properties as nasal drops.
下記処方にしたがってチューインガムを調製した。
ガムベース 20.0%
砂糖 54.7
グルコース 15.0
水飴 9.3
香料 0.5
試料調製例2のバナナ抽出物 0.5
100.0%
Chewing gum was prepared according to the following formulation.
Gum base 20.0%
Sugar 54.7
Glucose 15.0
Minamata 9.3
Fragrance 0.5
Banana extract of Sample Preparation Example 2 0.5
100.0%
上記と同じ配合比率で、バナナ抽出物の代わりに試料調製例1乃至試料調製例8の各抽出物を配合したチューインガムをそれぞれ同様に調製した。これらはチューインガムとしての性質を損なうことなく線毛運動活性化効果を有していた。 In the same blending ratio as above, chewing gums blended with the extracts of Sample Preparation Example 1 to Sample Preparation Example 8 instead of the banana extract were similarly prepared. These had a ciliary movement activation effect without impairing the properties as chewing gum.
下記処方にしたがってチューインガムを調製した。
ガムベース 20.0%
砂糖 54.5
グルコース 10.0
水飴 13.0
香料 0.5
試料調製例4のバナナ抽出物 1.0
試料調製例4のセキショウ抽出物 1.0
100.0%
Chewing gum was prepared according to the following formulation.
Gum base 20.0%
Sugar 54.5
Glucose 10.0
Minamata 13.0
Fragrance 0.5
Banana extract of Sample Preparation Example 4 1.0
The extract of sample preparation 4 was 1.0.
100.0%
上記と同じ配合比率で、バナナ抽出物、セキショウ抽出物の代わりに試料調製例1乃至試料調製例8の各抽出物を配合したチューインガムをそれぞれ同様に調製した。これらはチューインガムとしての性質を損なうことなく線毛運動活性化効果を有していた。 Chewing gums containing the extracts of Sample Preparation Example 1 to Sample Preparation Example 8 in the same manner as described above were prepared in the same manner in place of the banana extract and the pepper extract. These had a ciliary movement activation effect without impairing the properties as chewing gum.
下記処方にしたがってチューインガムを調製した。
ガムベース 20.0%
砂糖 50.5
グルコース 14.0
水飴 13.0
香料 0.5
試料調製例8のダイダイ抽出物 2.0
100.0%
Chewing gum was prepared according to the following formulation.
Gum base 20.0%
Sugar 50.5
Glucose 14.0
Minamata 13.0
Fragrance 0.5
Die-dye extract of Sample Preparation Example 2.0
100.0%
上記と同じ配合比率で、ダイダイ抽出物の代わりに試料調製例1乃至試料調製例8の各抽出物を配合したチューインガムをそれぞれ同様に調製した。これらはチューインガムとしての性質を損なうことなく線毛運動活性化効果を有していた。 In the same blending ratio as above, chewing gums blended with the extracts of Sample Preparation Example 1 to Sample Preparation Example 8 instead of Daidai Extract were similarly prepared. These had a ciliary movement activation effect without impairing the properties as chewing gum.
下記処方にしたがってキャンディを調製した。
砂糖 50.0%
水飴 33.0
クエン酸 1.0
香料 0.2
L−メントール 1.0
試料調製例2のバナナ抽出物 0.4
水 14.4
100.0%
Candy was prepared according to the following formulation.
Sugar 50.0%
Minamata 33.0
Citric acid 1.0
Fragrance 0.2
L-Menthol 1.0
Banana extract of Sample Preparation Example 2 0.4
Water 14.4
100.0%
上記と同じ配合比率で、バナナ抽出物の代わりに試料調製例1乃至試料調製例8の各抽出物を配合したキャンディをそれぞれ同様に調製した。これらはキャンディとしての性質を損なうことなく線毛運動活性化効果を有していた。 Candy in which the extracts of Sample Preparation Example 1 to Sample Preparation Example 8 were mixed in the same manner as described above instead of the banana extract was prepared in the same manner. These had a ciliary movement activation effect without impairing the properties as candy.
下記処方にしたがってキャンディを調製した。
砂糖 38.0%
水飴 41.0
クエン酸 1.0
香料 0.2
粉末バナナ(皮) 1.4
水 18.4
100.0%
Candy was prepared according to the following formulation.
Sugar 38.0%
Minamata 41.0
Citric acid 1.0
Fragrance 0.2
Powdered banana (skin) 1.4
Water 18.4
100.0%
上記と同じ配合比率で、粉末バナナ(皮)の代わりに粉末ニクズク及び/又は粉末レモンを配合したキャンディをそれぞれ同様に調製した。これらはキャンディとしての性質を損なうことなく線毛運動活性化効果を有していた。 Candy in which powdered nutmeg and / or powdered lemon was blended instead of powdered banana (skin) at the same blending ratio as above was similarly prepared. These had a ciliary movement activation effect without impairing the properties as candy.
下記処方にしたがってキャンディを調製した。
砂糖 38.0%
水飴 32.0
キシリトール 10.0
クエン酸 1.0
香料 0.2
試料調製例4のキシュウミカン抽出物 0.4
水 18.4
100.0%
Candy was prepared according to the following formulation.
Sugar 38.0%
Minamata 32.0
Xylitol 10.0
Citric acid 1.0
Fragrance 0.2
Chrysanthemum extract of Sample Preparation Example 4 0.4
Water 18.4
100.0%
上記と同じ配合比率で、キシュウミカン抽出物の代わりに試料調製例1乃至試料調製例8の各抽出物を配合したキャンディをそれぞれ同様に調製した。これらはキャンディとしての性質を損なうことなく線毛運動活性化効果を有していた。 Candy in which each of the extracts of Sample Preparation Example 1 to Sample Preparation Example 8 was mixed in the same manner as above was used in the same manner. These had a ciliary movement activation effect without impairing the properties as candy.
下記処方にしたがってチョコレートを調製した。
カカオビター 20.0 %
全脂粉乳 20.0
カカオバター 17.0
粉糖 41.85
レシチン 0.45
香料 0.1
試料調製例4のハス抽出物 0.6
100.0 %
Chocolate was prepared according to the following formulation.
Cocoa bitter 20.0%
Whole milk powder 20.0
Cocoa butter 17.0
Powdered sugar 41.85
Lecithin 0.45
Fragrance 0.1
Lotus extract of Sample Preparation Example 4 0.6
100.0%
上記と同じ配合比率で、ハス抽出物の代わりに試料調製例1乃至試料調製例8の各抽出物を配合したチョコレートをそれぞれ同様に調製した。これらはチョコレートとしての性質を損なうことなく線毛運動活性化効果を有していた。 The chocolate which mix | blended each extract of sample preparation example 1 thru | or sample preparation example 8 instead of the lotus extract was similarly prepared by the same mixing | blending ratio as the above. These had a ciliary movement activation effect without impairing the properties as chocolate.
下記処方にしたがってビスケットを調製した。
砂糖 31.7%
小麦粉 26.8
片栗粉 26.8
バター 3.2
卵 10.7
重曹 0.3
試料調製例1のリョウリバナナ抽出物 0.5
100.0%
Biscuits were prepared according to the following recipe.
31.7% sugar
Flour 26.8
Starch flour 26.8
Butter 3.2
Egg 10.7
Baking soda 0.3
Ryoori banana extract of Sample Preparation Example 1 0.5
100.0%
上記と同じ配合比率で、リョウリバナナ抽出物の代わりに試料調製例1乃至試料調製例8の各抽出物を配合したビスケットをそれぞれ同様に調製した。これらはビスケットとしての性質を損なうことなく線毛運動活性化効果を有していた。 Biscuits in which the extracts of Sample Preparation Example 1 to Sample Preparation Example 8 were mixed in the same manner in the same mixing ratio as above were used instead of the ryoli banana extract. They had a ciliary movement activation effect without impairing the properties as biscuits.
下記処方にしたがってグミゼリーを調製した。
ポリデキストロース水溶液 40.0%
ソルビトール水溶液 8.0
パラチノース水溶液 9.0
マルトース水溶液 20.0
トレハロース水溶液 11.0
ゼラチン 10.0
酒石酸 1.0
試料調製例8のセキショウ抽出物 1.0
100.0%
Gummy jelly was prepared according to the following formulation.
Polydextrose aqueous solution 40.0%
Sorbitol aqueous solution 8.0
Palatinose aqueous solution 9.0
Maltose aqueous solution 20.0
Trehalose aqueous solution 11.0
Gelatin 10.0
Tartaric acid 1.0
The extract of sample preparation 8 was 1.0.
100.0%
上記と同じ配合比率で、セキショウ抽出物の代わりに試料調製例1乃至試料調製例8の各抽出物を配合したグミゼリーをそれぞれ同様に調製した。これらはグミゼリーとしての性質を損なうことなく線毛運動活性化効果を有していた。 Gummy jelly blended with the extracts of Sample Preparation Example 1 to Sample Preparation Example 8 in the same manner in place of the pepper extract was prepared in the same manner. These had ciliary motility activation effect without impairing the properties of gummy jelly.
下記処方にしたがって錠菓を調製した。
砂糖 76.1%
グルコース 19.0
ショ糖脂肪酸エステル 0.2
香料 0.2
試料調製例7のリョウリバナナ抽出物 0.5
水 4.0
100.0%
Tablet confectionery was prepared according to the following formulation.
76.1% sugar
Glucose 19.0
Sucrose fatty acid ester 0.2
Fragrance 0.2
Ryori banana extract of Sample Preparation Example 7 0.5
Water 4.0
100.0%
上記と同じ配合比率で、リョウリバナナ抽出物の代わりに試料調製例1乃至試料調製例8の各抽出物を配合した錠菓をそれぞれ同様に調製した。これらは錠菓としての性質を損なうことなく線毛運動活性化効果を有していた。 Tablets containing the extracts of Sample Preparation Example 1 to Sample Preparation Example 8 in the same manner as described above were prepared in the same manner in place of the ryoli banana extract. These had a ciliary movement activation effect without impairing the properties as a tablet confectionery.
下記処方にしたがって錠菓を調製した。
砂糖 74.7 %
乳糖 18.9
ショ糖脂肪酸エステル 0.15
試料調製例1のセイヨウサンザシ抽出物 1.0
試料調製例4のレモン抽出物 1.0
水 4.25
100.0 %
Tablet confectionery was prepared according to the following formulation.
74.7% sugar
Lactose 18.9
Sucrose fatty acid ester 0.15
Hawthorn extract of sample preparation example 1 1.0
Lemon extract of sample preparation example 4 1.0
Water 4.25
100.0%
上記と同じ配合比率で、セイヨウサンザシ抽出物、レモン抽出物の代わりに試料調製例1乃至試料調製例8の各抽出物を配合した錠菓をそれぞれ同様に調製した。これらは錠菓としての性質を損なうことなく線毛運動活性化効果を有していた。 Tablets containing the extracts of Sample Preparation Example 1 to Sample Preparation Example 8 instead of hawthorn extract and lemon extract were prepared in the same manner at the same mixing ratio as above. These had a ciliary movement activation effect without impairing the properties as a tablet confectionery.
下記処方にしたがってアイスクリームを調製した。
卵黄 11.0%
砂糖 14.0
牛乳 37.0
生クリーム 37.0
バニラビーンズ 0.5
試料調製例2のクマザサ抽出物 0.5
100.0%
Ice cream was prepared according to the following formulation.
Yolk 11.0%
Sugar 14.0
Milk 37.0
Fresh cream 37.0
Vanilla beans 0.5
Kumazasa Extract of Sample Preparation Example 2 0.5
100.0%
上記と同じ配合比率で、クマザサ抽出物の代わりに試料調製例1乃至試料調製例8の各抽出物を配合したアイスクリームをそれぞれ同様に調製した。これらはアイスクリームとしての性質を損なうことなく線毛運動活性化効果を有していた。 Ice creams containing the extracts of Sample Preparation Example 1 to Sample Preparation Example 8 were prepared in the same manner in the same mixing ratio as above, instead of Kumazasa extract. These had a ciliary movement activation effect without impairing the properties of ice cream.
下記処方にしたがってシャーベットを調製した。
オレンジ果汁 16.0%
砂糖 32.0
試料調製例3のマライヤマバショウ抽出物 2.0
水 50.0
100.0%
A sherbet was prepared according to the following formulation.
Orange juice 16.0%
Sugar 32.0
Malayan bay pepper extract of Sample Preparation Example 3 2.0
Water 50.0
100.0%
上記と同じ配合比率で、マライヤマバショウ抽出物の代わりに試料調製例1乃至試料調製例8の各抽出物を配合したシャーベットをそれぞれ同様に調製した。これらはシャーベットとしての性質を損なうことなく線毛運動活性化効果を有していた。 The sherbet which mix | blended each extract of the sample preparation example 1 thru | or the sample preparation example 8 instead of the Malayan bay shoot extract was similarly prepared with the same mixture ratio as the above. These had a ciliary movement activation effect without impairing the properties as a sherbet.
下記処方にしたがって飲料を調製した。
オレンジ果汁 30.0 %
異性化糖 15.24
クエン酸 0.1
ビタミンC 0.04
香料 0.1
試料調製例6のクコ抽出物 0.1
水 54.42
100.0 %
A beverage was prepared according to the following formulation.
Orange juice 30.0%
Isomerized sugar 15.24
Citric acid 0.1
Vitamin C 0.04
Fragrance 0.1
Wolfberry extract of sample preparation example 6 0.1
Water 54.42
100.0%
上記と同じ配合比率で、クコ抽出物の代わりに試料調製例1乃至試料調製例8の各抽出物を配合した飲料をそれぞれ同様に調製した。これらは飲料としての性質を損なうことなく線毛運動活性化効果を有していた。 Beverages blended with the extracts of Sample Preparation Example 1 to Sample Preparation Example 8 instead of the wolfberry extract were prepared in the same manner at the same blending ratio as above. These had a ciliary movement activation effect without impairing the properties as a beverage.
下記処方にしたがって錠剤を調製した。
D−マンニトール 43.0%
乳糖 43.0
結晶セルロース 9.0
ヒドロキシプロピルセルロース 4.0
L−メントール 1.0
100.0%
Tablets were prepared according to the following formulation.
D-mannitol 43.0%
Lactose 43.0
Crystalline cellulose 9.0
Hydroxypropylcellulose 4.0
L-Menthol 1.0
100.0%
上記と同じ配合比率で、L−メントールの代わりにD−メントール、メンチルアセテート、イソメントールのうちの何れかを配合した錠剤をそれぞれ同様に調製した。これらは錠剤としての性質を損なうことなく線毛運動活性化効果を有していた。 Tablets containing any of D-menthol, menthyl acetate and isomenthol instead of L-menthol were prepared in the same manner at the same mixing ratio as above. These had a ciliary movement activation effect without impairing the properties as a tablet.
下記処方にしたがって散剤を調製した。
乳糖 67.5%
馬鈴薯でんぷん 30.0
L−メントール 2.5
100.0%
A powder was prepared according to the following formulation.
Lactose 67.5%
Potato starch 30.0
L-Menthol 2.5
100.0%
上記と同じ配合比率で、L−メントールの代わりにD−メントール、メンチルアセテート、イソメントールのうちの何れかを配合した散剤をそれぞれ同様に調製した。これらは散剤としての性質を損なうことなく線毛運動活性化効果を有していた。 Powders containing any of D-menthol, menthyl acetate and isomenthol instead of L-menthol were prepared in the same manner at the same mixing ratio as above. These had a ciliary movement activation effect without impairing the properties as a powder.
下記処方にしたがって吸入剤を調製した。
エタノール 5.0%
L−メントール 1.5
D−メントール 1.5
水 92.0
100.0%
An inhalant was prepared according to the following formulation.
Ethanol 5.0%
L-Menthol 1.5
D-Menthol 1.5
Water 92.0
100.0%
上記と同じ配合比率で、L−メントール、D−メントールの代わりにメンチルアセテート、イソメントールのうちの何れかを配合した吸入剤をそれぞれ同様に調製した。これらは吸入剤としての性質を損なうことなく線毛運動活性化効果を有していた。 Inhalants containing either menthyl acetate or isomenthol instead of L-menthol and D-menthol were prepared in the same manner at the same blending ratio as above. These had a ciliary movement activation effect without impairing the properties as an inhalant.
下記処方にしたがってチューインガムを調製した。
ガムベース 20.0%
砂糖 55.0
グルコース 15.0
水飴 9.4
香料 0.5
L−メントール 0.1
100.0%
Chewing gum was prepared according to the following formulation.
Gum base 20.0%
Sugar 55.0
Glucose 15.0
Minamata 9.4
Fragrance 0.5
L-Menthol 0.1
100.0%
上記と同じ配合比率で、L−メントールの代わりにD−メントール、メンチルアセテート、イソメントールのうちの何れかを配合したチューインガムをそれぞれ同様に調製した。これらはチューインガムとしての性質を損なうことなく線毛運動活性化効果を有していた。 In the same blending ratio as above, chewing gums blended with any of D-menthol, menthyl acetate and isomenthol instead of L-menthol were prepared in the same manner. These had a ciliary movement activation effect without impairing the properties as chewing gum.
下記処方にしたがってキャンディを調製した。
砂糖 39.0%
水飴 41.2
クエン酸 1.0
香料 0.2
メンチルアセテート 0.1
水 18.5
100.0%
Candy was prepared according to the following formulation.
Sugar 39.0%
Minamata 41.2
Citric acid 1.0
Fragrance 0.2
Menthyl acetate 0.1
Water 18.5
100.0%
上記と同じ配合比率で、メンチルアセテートの代わりにL−メントール、D−メントール、イソメントールのうちの何れかを配合したキャンディをそれぞれ同様に調製した。これらはキャンディとしての性質を損なうことなく線毛運動活性化効果を有していた。 Candy in which any one of L-menthol, D-menthol, and isomenthol was blended in place of menthyl acetate at the same blending ratio was prepared in the same manner. These had a ciliary movement activation effect without impairing the properties as candy.
下記処方にしたがってキャンディを調製した。
砂糖 38.0%
水飴 32.0
キシリトール 10.0
クエン酸 1.0
香料 0.2
L−メントール 0.2
メンチルアセテート 0.2
水 18.4
100.0%
Candy was prepared according to the following formulation.
Sugar 38.0%
Minamata 32.0
Xylitol 10.0
Citric acid 1.0
Fragrance 0.2
L-Menthol 0.2
Menthyl acetate 0.2
Water 18.4
100.0%
上記と同じ配合比率で、L−メントール、メンチルアセテートの代わりにD−メントール、イソメントールのうちの何れかを配合したキャンディをそれぞれ同様に調製した。これらはキャンディとしての性質を損なうことなく線毛運動活性化効果を有していた。 Candy in which any of D-menthol and isomenthol was blended in place of L-menthol and menthyl acetate at the same blending ratio was prepared in the same manner. These had a ciliary movement activation effect without impairing the properties as candy.
下記処方にしたがって飲料を調製した。
オレンジ果汁 30.00%
異性化糖 15.26
クエン酸 0.10
ビタミンC 0.07
香料 0.10
メンチルアセテート 0.05
水 54.42
100.0 %
A beverage was prepared according to the following formulation.
Orange juice 30.00%
Isomerized sugar 15.26
Citric acid 0.10
Vitamin C 0.07
Fragrance 0.10
Menthyl acetate 0.05
Water 54.42
100.0%
上記と同じ配合比率で、メンチルアセテートの代わりにL−メントール、D−メントール、イソメントールのうちの何れかを配合した飲料をそれぞれ同様に調製した。これらは飲料としての性質を損なうことなく線毛運動活性化効果を有していた。 Beverages blended with any of L-menthol, D-menthol, and isomenthol instead of menthyl acetate at the same blending ratio as above were prepared in the same manner. These had a ciliary movement activation effect without impairing the properties as a beverage.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012055191A JP5677342B2 (en) | 2012-03-12 | 2012-03-12 | Pili movement activator |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012055191A JP5677342B2 (en) | 2012-03-12 | 2012-03-12 | Pili movement activator |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006023975A Division JP5189735B2 (en) | 2006-01-31 | 2006-01-31 | Pili movement activator |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012131822A JP2012131822A (en) | 2012-07-12 |
JP5677342B2 true JP5677342B2 (en) | 2015-02-25 |
Family
ID=46647814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012055191A Expired - Fee Related JP5677342B2 (en) | 2012-03-12 | 2012-03-12 | Pili movement activator |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5677342B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6411778B2 (en) * | 2014-06-06 | 2018-10-24 | 日本メナード化粧品株式会社 | Stem cell undifferentiated state maintenance agent and growth promoter |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6259219A (en) * | 1985-09-10 | 1987-03-14 | Ikeda Mohandou:Kk | Antitussive, expectorant, analgesic and sedative agent for external use |
JP4098857B2 (en) * | 1997-10-27 | 2008-06-11 | 日清丸紅飼料株式会社 | Preventive and therapeutic agents for pig diseases |
JP4979181B2 (en) * | 2003-01-31 | 2012-07-18 | 株式会社ヤクルト本社 | Glycation inhibitors and uses thereof |
-
2012
- 2012-03-12 JP JP2012055191A patent/JP5677342B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2012131822A (en) | 2012-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5189735B2 (en) | Pili movement activator | |
US8084061B2 (en) | Body fat-reducing agent | |
JP2009126853A (en) | Therapeutic agent | |
JP2003192605A (en) | Lipase inhibitant | |
JP4669670B2 (en) | Anti-influenza virus agent and influenza infection suppression product obtained by adsorbing, impregnating and adding the same | |
KR102252126B1 (en) | Composition for prevention or treatment respiratory diseases comprising combination extracts of Chrysanthemum morifolium Ramatuelle and Scutellaria baicalensis as an active ingredient | |
JP2006316053A (en) | Cytotoxic inhibitors and their uses | |
KR102507666B1 (en) | Health Functional beverage composition, Health Functional beverage comprising same and preparing method of the same | |
JP2001252054A (en) | Food composition | |
JP5677342B2 (en) | Pili movement activator | |
JP2012131823A (en) | Activator of ciliary movement, and food and drink containing the same | |
JP7354448B2 (en) | Composition for improving asthma | |
JP2008115138A (en) | Leukotriene production retarder, and food and drink containing the same | |
JP2005281271A (en) | Skin moisturizing ability improving agent | |
JP2004323439A (en) | Composition for ameliorating blood viscosity | |
JP2010180141A (en) | Anti-allergic composition | |
KR100877220B1 (en) | Linear hair activator and food containing it | |
JP5969308B2 (en) | Nitric oxide secretion promoter or secretion inducer of vascular endothelial cells | |
JP2011026268A (en) | Antiallergic agent | |
FR3057777A1 (en) | COMPOSITION FOR EXPECTORIZING AND DECONGESTING THE RESPIRATORY TRACT, METHOD FOR PREPARING THE SAME AND USE THEREOF | |
KR20220078762A (en) | An Antitussive and Expectorant Composition Comprising Extract of Hibiscus Syriacus Flower | |
KR101715154B1 (en) | Composition comprising an extract or a fraction of Buxus koreana for preventing or treating asthma | |
JP5343016B2 (en) | Anti-influenza virus agent and influenza infection suppression product obtained by adsorbing, impregnating and adding the same | |
JP5303482B2 (en) | Anti-influenza virus agent and influenza infection suppression product obtained by adsorbing, impregnating and adding the same | |
WO2021221577A2 (en) | Formulations of food supplement comprising natural sweetener |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131108 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140106 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140606 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140724 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20141203 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20141226 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5677342 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |